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Abstract: Background: Impaired nocturnal mobility is a well-known problem in Parkinson's disease 
(PD), and clinical experience suggests a predominance of supine body position during sleep. However, 
this assumption - and potential consequences - still awaits objective validation by a polysomnography-
based and adequately controlled study.  
Methods: Clinical and polysomnographical analysis of 80 consecutive PD patients and 80 control 
subjects carefully matched for age, sex, body mass index and apnea-hypopnea index. 
Results: PD patients slept twice as much in supine position than control subjects (62.2±32.9% vs. 
34.2±28.5%, p<0.001). In PD, but not in control subjects, more supine sleep correlated with fewer 
changes in body position (rho=-0.434, p<0.001). Longer PD disease duration was an independent 
predictor of more supine sleep in multiple linear regression analysis (β=0.389, p<0.001); conversely, 
more supine sleep was associated with higher apnea-hypopnea index and daytime sleepiness. 
Conclusions: We confirmed that supine sleep is common in PD, and increases with longer disease 
duration. Our findings indicate that supine sleep may contribute to the overall disease burden by 
deteriorating sleep-disordered breathing and daytime vigilance. 
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Reviewer #1 
Sleep disorders are such complex problems that one must be careful in deducing too much, especially 
from a single, retrospective study. Your study appears to have been well done and the ms is well 
written. I have some reservations and suggestions. 
We thank Reviewer #1 for this encouraging comment and the helpful suggestions. 
In the highlights section, I suggest noting on the first line that this was a retrospective study. This 
indicates to the reader that you were unable to control for many variables that might be important.  
We added a statement that this was a retrospective study. 
In the introduction, I suggest deleting the statement that "nocturnal immobility is recognized as a 
disease-defining feature." Perhaps you mean "common disease feature?" I am not aware of any 
criteria for defining PD that include nocturnal immobility. 
We changed the wording according to the reviewer’s suggestion. 
I applaud your matching PD and controls for BMI and AHI, but, as you know, there are many other 
items you might have chosen. Your mean ages were the same. Did you purposely match for age? 
Please state. 
Thank you for this comment. We understand that perfect matching is not feasible. For this 
study, we deliberately matched the two groups for age, sex, BMI and AHI, because we believe 
these four factors most likely impact the distribution of different body positions during sleep.  
You state that one body position you measured was "upright." Did some subjects sleep upright in a 
bed? Please clarify 
The used sensor is able to detect “upright” body position, i.e. when sitting or standing up; 
however, no sleep in this position was detected in this study. We apologize for this confusion 
and have now clarified this issue in the Methods section. 
You state that "probably only few conditions lead to such a pronounced increment in supine..." Unless 
you have data to support this, I suggest deleting. I suspect that many neurological and orthopedic 
disorders are associated with this, and, in the U.S., pediatricians now have babies sleep on their backs 
to avoid SIDS. This might possibly lead to most adults learning to do this.  
We deleted this statement, as we indeed lack any supporting data.  
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Most importantly, you need to list the many weaknesses in your study. We have no information on why 
sleep studies were obtained, which may have been quite different in the two groups. We don't know 
how many were smokers, had pain syndromes, had back problems, had RBD, had breathing 
disorders, were obese, what medications they took, whether supine sleeping correlated with nocturia, 
etc etc. You don't have to list every issue you can think of, but you should mention a few since they 
are relevant and impossible to match for.  
Thank you for these suggestions. We appreciate your concerns, and are now discussing the 
limitations inherent to such a retrospective study in more detail.  
Most importantly, you should acknowledge that you found correlations, not cause and effect 
relationships. You have not provided any data to indicate that less sleeping supine is helpful. Perhaps 
a trial of having people sleep with something like a small ball attached to their sleep attire to make it 
impossible to sleep supine would be an inexpensive intervention to test your hypothesis. 
I am not sure many will agree with your suggestion to include supine sleeping in studies of treatment 
interventions. There are so many possible things to study and your single study does not evaluate 
effects of reducing the time in the supine position. 
We agree that our non-interventional study does not provide any evidence that improved 
nocturnal mobility and less supine sleep would also lead to meaningful changes in quality of 
life of PD patients. We understand the difference between correlation and cause and effect 
relationship, and have now tempered our conclusions accordingly.  
However, we do believe supine sleep and nocturnal immobility should be addressed in studies 
on sleep quality in PD and that this issue has so far been too neglected. 
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Reviewer #2 
The primary aim of this article is to determine body position of PD patients during sleep. This can be 
determined also by sleep partner report or videography. Expensive polysomnogram is not needed. 
Patients were selected retrospectively from referrals to a sleep lab. Since it is not routine practice to 
order PSG for all PD patients, presumably these PD patients had suspicion of possible sleep apnea so 
they were referred for PSG. The data or these patients cannot be extrapolated to all PD patients. 
We absolutely agree that polysomnography is expensive and information on body position 
could be achieved cheaper and by other means. Indeed, among our patients, no 
polysomnography was actually done primarily to assess distribution of body positions during 
sleep. Rather we wished to benefit from the many polysomnographies that had been 
performed in PD patients in our department, and set out to analyze, whether PD patients really 
do sleep more in supine position.  
We also agree that a potential referral bias cannot be excluded. However, we believe we 
reasonably accounted for this risk by using a rater-independent propensity score matching 
with inclusion of four major variables. In addition, due to the high prevalence of sleep-wake 
disturbances in PD and their possible diagnostic, therapeutic and medico-legal implications, 
polysomnography has become an integral diagnostic procedure in PD patients in our 
department. Thus, a significant referral bias seems quite unlikely, because polysomnography 
was performed in most PD patients independent of the presence or absence of (suspected) 
sleep apnea or any other sleep disorder.  
We admit, on the other hand, that our PD population is representative for a tertiary center, and 
our findings cannot be generalized to all PD patients. 
We added these limitations to our discussion. 
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Reviewer #3 
This is an interesting and well written paper confirming that supine sleep is, first, more common in PD 
than in normal controls and second, increases with disease duration. Reported below, there are a few 
questions that add more information.  
We thank Reviewer #3 for this appraisal of our study. 
1. The multiple regression included disease type and found no influence of disease type with the 
akinetic-rigid form. However other type of approach could be used to determine whether there might 
be some association between this form and the propensity for supine position during sleep, such as 
cluster analyses or group comparisons.   
We also calculated a group comparison (ANOVA) for association of disease type with amount 
of supine sleep; we did not find significant differences in this analysis (in 2 patients, disease 
type was missing). 
type n mean p 
akinetic/rigid 58 62.3 
0.821 tremor dominant 15 64.4 
equal 5 52.7 
 
2. The second question is about dopaminergic medications, in terms of type and timing of the last 
dose. Specifically, first, from the data is it possible to understand whether dopaminergic agonists were 
more often associated with propensity for supine position? Second, was there an effect of the time of 
the last dose of dopaminergic medication before sleep? 
We calculated a group comparison (student’s T-test) for differences of percent of supine sleep 
position between patients with and without dopamine agonists but did not find significant 
differences (67% versus 55%, p=0.12). 
We also performed correlation analysis of amount of supine sleep position with levodopa 
equivalent dose of dopamine agonist and long acting dopaminergics at bedtime (night dose of 
levodopa with continuous release and long acting dopamine agonists) but did not find any 
significant association. However, we could not elucidate the specific time of dosing due to 
insufficient data in our chart review. 
We added both use of dopaminergic agonists and use of long acting dopaminergics in the 
multivariate regression analysis, which did not change the result, and disease duration 
remained the only predictor of more supine sleep position. 
As our study was non-interventional and PD groups with and without long acting 
dopaminergics (or w/o dopamine agonists) were not perfectly matched, estimations from these 
preliminary calculations are difficult to generalize. We included this in our limitation paragraph. 
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3. Did the author explore possible relation between PSG findings and time of supine position?  
We did correlation analysis of all polysomnographic findings listed in Table1 and below; 
however, we did not find any significant correlation (Pearson’s r). We summarized these 
negative findings in the Result section (“supine sleep position did not correlate with any sleep 
stage, sleep efficiency or arousal index”). 
Supine position [%] Pearson’s r p 
Total sleep time [min] ,035 0.756 
Sleep latency [min] ,017 0.883 
Sleep efficiency [%] -,003 0.982 
Wake [%] ,024 0.833 
Rapid eye movement (REM) sleep [%] -,006 0.961 
Non-REM sleep 1 [%] ,065 0.571 
Non-REM sleep 2 [%] -,089 0.434 
Slow wave sleep [%] ,036 0.750 
Periodic limb movements in sleep [/h] -,066 0.564 
 
4. Finally, a graph about the correlation between disease duration and more supine sleep in PD 
should be added in Figure 1. 
We added a scatter plot to figure 1. 
We thank Reviewer #3 for the helpful comments. 
Highlights 
 We retrospectively analyzed 80 PD patients and 80 matched controls by 
polysomnography 
 PD patients slept twice as much in supine position than controls 
 More supine sleep correlated with fewer changes in body position in PD 
 Longer PD disease duration was an independent predictor of more supine sleep 
 More supine sleep was associated with higher AHI and daytime sleepiness in PD 
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Abstract 
Background: Impaired nocturnal mobility is a well-known problem in Parkinson’s disease 
(PD), and clinical experience suggests a predominance of supine body position during sleep. 
However, this assumption – and potential consequences – still awaits objective validation by 
a polysomnography-based and adequately controlled study.  
Methods: Clinical and polysomnographical analysis of 80 consecutive PD patients and 80 
control subjects carefully matched for age, sex, body mass index and apnea-hypopnea 
index. 
Results: PD patients slept twice as much in supine position than control subjects 
(62.2±32.9% vs. 34.2±28.5%, p<0.001). In PD, but not in control subjects, more supine sleep 
correlated with fewer changes in body position (rho=-0.434, p<0.001). Longer PD disease 
duration was an independent predictor of more supine sleep in multiple linear regression 
analysis (β=0.389, p<0.001); conversely, more supine sleep was associated with higher 
apnea-hypopnea index and daytime sleepiness. 
Conclusions: We confirmed that supine sleep is common in PD, and increases with longer 
disease duration. Our findings indicate that supine sleep may contribute to the overall 
disease burden by deteriorating sleep-disordered breathing and daytime vigilance. 
 
 
Key Words: Parkinson’s disease, nocturnal immobility, supine, sleep position, sleepiness, 
sleep-disordered breathing 
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Introduction 
A myriad of motor and non-motor symptoms add to the overall clinical burden in 
Parkinson’s disease (PD), and sleep-wake disturbances are among the most frequent and 
significant contributors [1]. Patients often complain about difficulty turning in bed and claim to 
sleep mostly in supine position. However, whether PD patients do sleep more in supine 
position is unclear, because researchers have rarely analyzed the distribution of sleep 
positions in PD. In contrast, nocturnal immobility is recognized as a common disease feature, 
and an item pertaining to this symptom has been included in several clinical scales, including 
the Parkinson’s Disease Quality of Life Questionnaire and the old and new versions of the 
Unified Parkinson’s Disease Rating Scale [2]. 
Few studies reported adverse effects of nocturnal immobility on sleep quality in PD, 
whereas a recent polysomnography-based study failed to detect differences in the 
distribution of sleep positions in PD patients with and without subjectively impaired bed 
mobility [3, 4]. Overall, most of these studies were based only on subjective complaints and 
lacked appropriate control groups.  
Thus, in the present study we aimed 1) at objectively comparing the distribution of 
distinct sleep positions and the frequency of body position changes between PD patients and 
carefully matched control subjects, and 2) at identifying clinical correlates and predictors of 
supine sleep position in PD.   
Patients and methods 
Subjects, clinical assessment and matching procedure 
 This was a retrospective chart review. In a first step, we selected 119 consecutive PD 
patients who received whole-night video-polysomnography (PSG) as an integral diagnostic 
procedure between 2004 and 2009. In order to compare their data on sleep positions and 
Sommerauer et al.  Sleep position in PD 
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nocturnal mobility to an adequate control group, we considered 248 consecutive non-
neurological patients from our data base, in which PSG was performed during the same time 
for suspected sleep disorders. We used propensity score matching as a rater-independent 
and unbiased method to generate two groups accurately matched for age, sex, body mass 
index (BMI, body mass divided by the square of individual’s height) and apnea-hypopnea 
index (AHI, number of apnea and hypopnea events per hour of sleep) [5]. By this means, we 
eventually included 80 PD patients and 80 matched control subjects.  
 Diagnostic procedure, clinical assessment and calculation of levodopa dose 
equivalents (LDE) are identical to previous studies [5]. We ascertained sleepiness using the 
Epworth Sleepiness Scale (ESS), with scores of ≥10 indicating excessive daytime sleepiness 
(EDS). The study was approved by the local Ethics Committee. 
Polysomnography assessment 
All patients had overnight PSG recordings, using a multi-channel recording system 
(Embla, RemLogicTM). Scoring of sleep stages and respiratory events was performed visually 
using standardized criteria [5]. Apnea was defined by a cessation of oro-nasal airflow longer 
than 10 seconds, and hypopnea by a reduction of oro-nasal airflow by at least 50% lasting 
more than 10 seconds and accompanied by an arousal or SaO2 reduction of ≥ 3%. A body 
position sensor was attached by an elastic velcro strap at the level of the lower sternum and 
recognized distinct body positions by virtue of different voltage outputs. This allowed for 
automatic detection of the following four body positions: supine, right, left, and prone. In 
theory, the sensor would also register upright body position, but our subjects did not sleep in 
this position. We ensured adequate monitoring by comparing patient video and body position 
recording. As an objective measure of nocturnal immobility we used the number of changes 
between distinct body positions per hour.  
Statistical analysis 
Sommerauer et al.  Sleep position in PD 
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Statistical analyses were performed using SPSS (version 21). Group data were 
described by means and standard deviations. For normally distributed data, we used 
Student’s t-test and for non-parametric data the Mann-Whitney U-test. Chi-square test was 
used for nominal data. We calculated Pearson’s r for correlation analysis of normally and 
Spearman-rho for non-normally distributed data. Stepwise multiple linear regression analysis 
was done including age, sex, body mass index, disease duration, Hoehn and Yahr stage, 
disease type, use of dopamine agonist, use of long acting dopaminergic medication, and 
total LDE as independent variables. Significance was accepted at p<0.05. 
Results 
Clinical and polysomnographic findings 
Demographic, clinical and polysomnographic findings are summerized in Table 1. PD 
patients slept roughly twice as much in supine position (62.2±32.9% vs. 34.2±28.5%, 
p<0.001), and had fewer body position changes than controls (4.2±7.1/h vs. 4.5±7.2/h, 
p=0.04). Lying most in supine position during sleep (≥90%) was more common among PD 
patients than controls (32% vs. 6%, p<0.001) (Fig. 1A). More supine sleep correlated with 
fewer body position changes in PD (rho=-0.434, p<0.001) but not in controls (rho=-0.200, 
p=0.08). 
Correlates of supine sleep position  
PD patients with EDS spent more time in supine position than those without EDS 
(51.0±35.2% vs. 75.4±25.0%, p=0.001), whereas controls did not differ in this respect 
(30.9±31.1% vs. 38.8±23.1%, p=0.07) (Fig. 1B). In PD, but not in controls, multiple linear 
regression analysis revealed that more supine sleep was independently associated with 
higher AHI (β=0.260, p=0.015 and age as second significant associate: β=0.349, p=0.001). 
Periodic limb movements in sleep did not correlate with supine position in either group. 
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Likewise, supine sleep position did not correlate with any sleep stage, sleep efficiency or 
arousal index, and group comparison did not reveal any difference in supine sleep between 
PD patients with various disease type (akinetic-rigid, tremor-dominant, equal). Finally, the 
use of dopamine agonists had no impact on total amount of supine position, and correlation 
analysis between LDE of dopamine agonists and of long-acting dopaminergic drugs at 
bedtime with supine position did not demonstrate any significant associations. 
Predictors of supine sleep in PD 
Linear regression analysis identified longer disease duration to be independently 
associated with more supine sleep in PD (β=0.389, p<0.001) (Fig. 1C). 
Discussion 
 Compared to carefully matched control subjects, PD patients slept almost twice as 
much in supine position and less often changed nocturnal body posture. In addition, we 
identified longer PD duration as independent predictor of more supine sleep. These results 
have been expected, and may be regarded as inevitable consequences of nocturnal 
immobility and axial rigidity. However, more than confirming a commonplace, our study 
suggests relevant clinical implications of this predominance for supine sleep position, as 
indicated by the association with increased severity of sleep-disordered breathing and 
excessive daytime sleepiness. 
Our knowledge about the distribution of sleep positions in general is limited, but the 
clinical impact of certain sleep positions has been acutely revealed by the discovery that 
prone sleep position is associated with a more than threefold increased risk of sudden infant 
death syndrome. Polysomnographic studies demonstrated that up to two thirds of patients 
with acute stroke spend the first nights nearly entirely in supine position, while the magnitude 
of supine sleep is likely to diminish following recovery [6]. In stroke patients, supine position 
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contributes to sleep disordered breathing (SDB) and impacts functional outcome and 
mortality. Application of continuous positive airway pressure (CPAP) or positional treatment 
is therefore increasingly advocated [7].  
In this line, our results and those of many other groups confirm that SDB is the most 
obvious problem caused by lying in supine position. Supine position increases the risk of 
upper airway collapses, causes more and longer apnoeic events, and necessitates a higher 
pressure from CPAP devices [8, 9]. Cheyne-Stokes respiration, obstructive and central SDB 
all ameliorate after changing from supine to lateral sleep position. Thus, our study indicates 
that sleep-related respiration in PD is similarly susceptible to the adverse effects of supine 
position. Although the contribution of SDB to daytime sleepiness has been questioned in PD, 
a recent randomized placebo-controlled study in PD patients with SDB demonstrated a 
significant improvement of both nocturnal sleep consolidation and objective daytime 
sleepiness in those receiving CPAP treatment [10]. Thus, feasability and efficacy of 
positional treatment – already a well established alternative to CPAP in patients with 
positional SDB [11] – need to be evaluated also in PD patients.  
On the other hand, it is unlikely that increased SDB severity represents the sole 
explanation for the negative association between supine sleep and daytime sleepiness. Even 
healthy people with poor sleep quality spend more time in supine position than good sleepers 
[12], and this observation suggests a mutual influence of supine position and poor sleep 
quality. In our study, however, we failed to demonstrate any correlation between 
polysomnographic measures of sleep consolidation and amount of supine position, which is 
in contrast to previous studies reporting an adverse impact of nocturnal immobility on 
subjective sleep quality. 
Our retrospective study has several limitations. Primarily, a selection bias cannot be 
ruled out, and polysomnography may have been differentially motivated in PD patients and 
controls. However, we believe we substantially reduced this risk by using a rater-independent 
propensity score matching with inclusion of four major variables. Moreover, due to the high 
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prevalence of sleep-wake disturbances in PD and their possible diagnostic, therapeutic and 
medico-legal implications, polysomnography has become an integral diagnostic procedure in 
PD patients in our department, and has thus been done largely independent of any 
suspected sleep disorder. Nevertheless, the potential influence on sleep position of 
additional features, including orthopedic comorbidity, smoking habits or nocturia, may have 
escaped our attention. Finally, since our study is purely observational, future work is required 
to confirm the clinical benefit obtained by decreased supine sleep, e.g. by using positioning 
device techniques such as tennis ball T-shirt or filled backpack. 
Overall, our study emphasizes the need for treatment strategies that help improving 
nocturnal mobility and liberating PD patients from their excessive supine recumbency. 
Studies evaluating the effects of long-lasting dopaminergic drugs, continuous dopaminergic 
stimulation or deep brain stimulation should therefore consider including supine sleep 
position as a possible end point when analyzing effects on sleep quality and daytime 
vigilance. 
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Table 1: Demographic, clinical and polysomnographic findings in PD patients and 
control subjects. 
 
 
PD patients 
(n=80) 
Control subjects 
(n=80) 
p 
    
Matched characteristics    
Age [y] 62.9 ± 8.6 63.4 ± 12.3 0.47 
Sex, female [n] 26 25 1.00 
Body mass index 25.9 ± 4.4 26.3 ± 3.9 0.49 
Apnea-hypopnea index [/h] 9.8 ± 15.4 10.5 ± 13.3 0.16 
    
    
Clinical findings    
Epworth sleepiness scale  9.6 ± 4.4 6.4 ± 6.2 0.001 
Epworth sleepiness scale ≥10  47% 36% 0.20 
    
    
PD characterstics    
Disease duration [y] 8.7 ± 6.5   
Unified Parkinson's Disease Rating Scale III 24.7 ± 12.7   
Hoehn and Yahr Stage 2.4 ± 0.8   
Akinetic-rigid disease type [%] 74.4   
Tremor-dominant disease type [%] 19.2   
Total levodopa dosage equivalent [mg] 551 ± 402   
    
    
Polysomnographic findings    
Total sleep time [min] 321 ± 84 334 ± 79 0.20 
Sleep latency [min] 35 ± 54 35 ± 45 0.53 
Sleep efficiency [%] 76 ± 16 77 ± 16 0.57 
Wake [%] 24 ± 16 24 ± 16 0.84 
Rapid eye movement (REM) sleep [%] 14 ± 7 12 ± 7 0.14 
Non-REM sleep 1 [%] 13 ± 8 14 ± 8 0.36 
Non-REM sleep 2 [%] 37 ± 12 36 ± 10 0.85 
Slow wave sleep [%] 12 ± 9 14 ± 8 0.20 
Periodic limb movements in sleep [/h] 12 ± 27 17 ± 28 0.04 
    
    
Sleep position characteristics    
Supine sleep position [%] 62.2 ± 32.9 34.2 ± 28.5 <0.001 
Lateral sleep position [%] 33.4 ± 30.5 60.0 ± 27.7 <0.001 
Prone sleep position [%] 3.6 ± 12.5 4.9 ± 12.8 0.05 
Transition index [/h] 4.2 ± 7.1 4.5 ± 7.2 0.04 
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Figure 1 Prevalence of supine sleep position in PD patients and control subjects 
and effects on daytime sleepiness 
A: Frequency and distribution in supine sleep position percentages differed 
significantly between Parkinson’s disease (PD) patients and control subjects 
(Co) (p<0.001). 
B: PD patients (black bars) with excessive daytime sleepiness (EDS) had 
more supine sleep than those without EDS (p=0.001). Control subjects (grey 
bars) did not differ in this respect (p=0.07). Error bars indicate standard 
deviations. 
C: PD patients with longer disease duration spent more time in supine body 
position (r=0.391, p<0.001). 
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Abstract 
Background: Impaired nocturnal mobility is a well-known problem in Parkinson’s disease 
(PD), and clinical experience suggests a predominance of supine body position during sleep. 
However, this assumption – and potential consequences – still awaits objective validation by 
a polysomnography-based and adequately controlled study.  
Methods: Clinical and polysomnographical analysis of 80 consecutive PD patients and 80 
control subjects carefully matched for age, sex, body mass index and apnea-hypopnea 
index. 
Results: PD patients slept twice as much in supine position than control subjects 
(62.2±32.9% vs. 34.2±28.5%, p<0.001). In PD, but not in control subjects, more supine sleep 
correlated with fewer changes in body position (rho=-0.434, p<0.001). Longer PD disease 
duration was an independent predictor of more supine sleep in multiple linear regression 
analysis (β=0.389, p<0.001); conversely, more supine sleep was associated with higher 
apnea-hypopnea index and daytime sleepiness. 
Conclusions: We confirmed that supine sleep is common in PD, and increases with longer 
disease duration. Our findings indicate that supine sleep may contribute to the overall 
disease burden by deteriorating sleep-disordered breathing and daytime vigilance. 
 
 
Key Words: Parkinson’s disease, nocturnal immobility, supine, sleep position, sleepiness, 
sleep-disordered breathing 
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Introduction 
A myriad of motor and non-motor symptoms add to the overall clinical burden in 
Parkinson’s disease (PD), and sleep-wake disturbances are among the most frequent and 
significant contributors [1]. Patients often complain about difficulty turning in bed and claim to 
sleep mostly in supine position. However, whether PD patients do sleep more in supine 
position is unclear, because researchers have rarely analyzed the distribution of sleep 
positions in PD. In contrast, nocturnal immobility is recognized as a common disease feature, 
and an item pertaining to this symptom has been included in several clinical scales, including 
the Parkinson’s Disease Quality of Life Questionnaire and the old and new versions of the 
Unified Parkinson’s Disease Rating Scale [2]. 
Few studies reported adverse effects of nocturnal immobility on sleep quality in PD, 
whereas a recent polysomnography-based study failed to detect differences in the 
distribution of sleep positions in PD patients with and without subjectively impaired bed 
mobility [3, 4]. Overall, most of these studies were based only on subjective complaints and 
lacked appropriate control groups.  
Thus, in the present study we aimed 1) at objectively comparing the distribution of 
distinct sleep positions and the frequency of body position changes between PD patients and 
carefully matched control subjects, and 2) at identifying clinical correlates and predictors of 
supine sleep position in PD.   
Patients and methods 
Subjects, clinical assessment and matching procedure 
 This was a retrospective chart review. In a first step, we selected 119 consecutive PD 
patients who received whole-night video-polysomnography (PSG) as an integral diagnostic 
procedure between 2004 and 2009. In order to compare their data on sleep positions and 
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nocturnal mobility to an adequate control group, we considered 248 consecutive non-
neurological patients from our data base, in which PSG was performed during the same time 
for suspected sleep disorders. We used propensity score matching as a rater-independent 
and unbiased method to generate two groups accurately matched for age, sex, body mass 
index (BMI, body mass divided by the square of individual’s height) and apnea-hypopnea 
index (AHI, number of apnea and hypopnea events per hour of sleep) [5]. By this means, we 
eventually included 80 PD patients and 80 matched control subjects.  
 Diagnostic procedure, clinical assessment and calculation of levodopa dose 
equivalents (LDE) are identical to previous studies [5]. We ascertained sleepiness using the 
Epworth Sleepiness Scale (ESS), with scores of ≥10 indicating excessive daytime sleepiness 
(EDS). The study was approved by the local Ethics Committee. 
Polysomnography assessment 
All patients had overnight PSG recordings, using a multi-channel recording system 
(Embla, RemLogicTM). Scoring of sleep stages and respiratory events was performed visually 
using standardized criteria [5]. Apnea was defined by a cessation of oro-nasal airflow longer 
than 10 seconds, and hypopnea by a reduction of oro-nasal airflow by at least 50% lasting 
more than 10 seconds and accompanied by an arousal or SaO2 reduction of ≥ 3%. A body 
position sensor was attached by an elastic velcro strap at the level of the lower sternum and 
recognized distinct body positions by virtue of different voltage outputs. This allowed for 
automatic detection of the following four body positions: supine, right, left, and prone. In 
theory, the sensor would also register upright body position, but our subjects did not sleep in 
this position. We ensured adequate monitoring by comparing patient video and body position 
recording. As an objective measure of nocturnal immobility we used the number of changes 
between distinct body positions per hour.  
Statistical analysis 
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Statistical analyses were performed using SPSS (version 21). Group data were 
described by means and standard deviations. For normally distributed data, we used 
Student’s t-test and for non-parametric data the Mann-Whitney U-test. Chi-square test was 
used for nominal data. We calculated Pearson’s r for correlation analysis of normally and 
Spearman-rho for non-normally distributed data. Stepwise multiple linear regression analysis 
was done including age, sex, body mass index, disease duration, Hoehn and Yahr stage, 
disease type, use of dopamine agonist, use of long acting dopaminergic medication, and 
total LDE as independent variables. Significance was accepted at p<0.05. 
Results 
Clinical and polysomnographic findings 
Demographic, clinical and polysomnographic findings are summerized in Table 1. PD 
patients slept roughly twice as much in supine position (62.2±32.9% vs. 34.2±28.5%, 
p<0.001), and had fewer body position changes than controls (4.2±7.1/h vs. 4.5±7.2/h, 
p=0.04). Lying most in supine position during sleep (≥90%) was more common among PD 
patients than controls (32% vs. 6%, p<0.001) (Fig. 1A). More supine sleep correlated with 
fewer body position changes in PD (rho=-0.434, p<0.001) but not in controls (rho=-0.200, 
p=0.08). 
Correlates of supine sleep position  
PD patients with EDS spent more time in supine position than those without EDS 
(51.0±35.2% vs. 75.4±25.0%, p=0.001), whereas controls did not differ in this respect 
(30.9±31.1% vs. 38.8±23.1%, p=0.07) (Fig. 1B). In PD, but not in controls, multiple linear 
regression analysis revealed that more supine sleep was independently associated with 
higher AHI (β=0.260, p=0.015 and age as second significant associate: β=0.349, p=0.001). 
Periodic limb movements in sleep did not correlate with supine position in either group. 
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Likewise, supine sleep position did not correlate with any sleep stage, sleep efficiency or 
arousal index, and group comparison did not reveal any difference in supine sleep between 
PD patients with various disease type (akinetic-rigid, tremor-dominant, equal). Finally, the 
use of dopamine agonists had no impact on total amount of supine position, and correlation 
analysis between LDE of dopamine agonists and of long-acting dopaminergic drugs at 
bedtime with supine position did not demonstrate any significant associations. 
Predictors of supine sleep in PD 
Linear regression analysis identified longer disease duration to be independently 
associated with more supine sleep in PD (β=0.389, p<0.001) (Fig. 1C). 
Discussion 
 Compared to carefully matched control subjects, PD patients slept almost twice as 
much in supine position and less often changed nocturnal body posture. In addition, we 
identified longer PD duration as independent predictor of more supine sleep. These results 
have been expected, and may be regarded as inevitable consequences of nocturnal 
immobility and axial rigidity. However, more than confirming a commonplace, our study 
suggests relevant clinical implications of this predominance for supine sleep position, as 
indicated by the association with increased severity of sleep-disordered breathing and 
excessive daytime sleepiness. 
Our knowledge about the distribution of sleep positions in general is limited, but the 
clinical impact of certain sleep positions has been acutely revealed by the discovery that 
prone sleep position is associated with a more than threefold increased risk of sudden infant 
death syndrome. Polysomnographic studies demonstrated that up to two thirds of patients 
with acute stroke spend the first nights nearly entirely in supine position, while the magnitude 
of supine sleep is likely to diminish following recovery [6]. In stroke patients, supine position 
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contributes to sleep disordered breathing (SDB) and impacts functional outcome and 
mortality. Application of continuous positive airway pressure (CPAP) or positional treatment 
is therefore increasingly advocated [7].  
In this line, our results and those of many other groups confirm that SDB is the most 
obvious problem caused by lying in supine position. Supine position increases the risk of 
upper airway collapses, causes more and longer apnoeic events, and necessitates a higher 
pressure from CPAP devices [8, 9]. Cheyne-Stokes respiration, obstructive and central SDB 
all ameliorate after changing from supine to lateral sleep position. Thus, our study indicates 
that sleep-related respiration in PD is similarly susceptible to the adverse effects of supine 
position. Although the contribution of SDB to daytime sleepiness has been questioned in PD, 
a recent randomized placebo-controlled study in PD patients with SDB demonstrated a 
significant improvement of both nocturnal sleep consolidation and objective daytime 
sleepiness in those receiving CPAP treatment [10]. Thus, feasability and efficacy of 
positional treatment – already a well established alternative to CPAP in patients with 
positional SDB [11] – need to be evaluated also in PD patients.  
On the other hand, it is unlikely that increased SDB severity represents the sole 
explanation for the negative association between supine sleep and daytime sleepiness. Even 
healthy people with poor sleep quality spend more time in supine position than good sleepers 
[12], and this observation suggests a mutual influence of supine position and poor sleep 
quality. In our study, however, we failed to demonstrate any correlation between 
polysomnographic measures of sleep consolidation and amount of supine position, which is 
in contrast to previous studies reporting an adverse impact of nocturnal immobility on 
subjective sleep quality. 
Our retrospective study has several limitations. Primarily, a selection bias cannot be 
ruled out, and polysomnography may have been differentially motivated in PD patients and 
controls. However, we believe we substantially reduced this risk by using a rater-independent 
propensity score matching with inclusion of four major variables. Moreover, due to the high 
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prevalence of sleep-wake disturbances in PD and their possible diagnostic, therapeutic and 
medico-legal implications, polysomnography has become an integral diagnostic procedure in 
PD patients in our department, and has thus been done largely independent of any 
suspected sleep disorder. Nevertheless, the potential influence on sleep position of 
additional features, including orthopedic comorbidity, smoking habits or nocturia, may have 
escaped our attention. Finally, since our study is purely observational, future work is required 
to confirm the clinical benefit obtained by decreased supine sleep, e.g. by using positioning 
device techniques such as tennis ball T-shirt or filled backpack. 
Overall, our study emphasizes the need for treatment strategies that help improving 
nocturnal mobility and liberating PD patients from their excessive supine recumbency. 
Studies evaluating the effects of long-lasting dopaminergic drugs, continuous dopaminergic 
stimulation or deep brain stimulation should therefore consider including supine sleep 
position as a possible end point when analyzing effects on sleep quality and daytime 
vigilance. 
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Table 1: Demographic, clinical and polysomnographic findings in PD patients and 
control subjects. 
 
 
PD patients 
(n=80) 
Control subjects 
(n=80) 
p 
    
Matched characteristics    
Age [y] 62.9 ± 8.6 63.4 ± 12.3 0.47 
Sex, female [n] 26 25 1.00 
Body mass index 25.9 ± 4.4 26.3 ± 3.9 0.49 
Apnea-hypopnea index [/h] 9.8 ± 15.4 10.5 ± 13.3 0.16 
    
    
Clinical findings    
Epworth sleepiness scale  9.6 ± 4.4 6.4 ± 6.2 0.001 
Epworth sleepiness scale ≥10  47% 36% 0.20 
    
    
PD characterstics    
Disease duration [y] 8.7 ± 6.5   
Unified Parkinson's Disease Rating Scale III 24.7 ± 12.7   
Hoehn and Yahr Stage 2.4 ± 0.8   
Akinetic-rigid disease type [%] 74.4   
Tremor-dominant disease type [%] 19.2   
Total levodopa dosage equivalent [mg] 551 ± 402   
    
    
Polysomnographic findings    
Total sleep time [min] 321 ± 84 334 ± 79 0.20 
Sleep latency [min] 35 ± 54 35 ± 45 0.53 
Sleep efficiency [%] 76 ± 16 77 ± 16 0.57 
Wake [%] 24 ± 16 24 ± 16 0.84 
Rapid eye movement (REM) sleep [%] 14 ± 7 12 ± 7 0.14 
Non-REM sleep 1 [%] 13 ± 8 14 ± 8 0.36 
Non-REM sleep 2 [%] 37 ± 12 36 ± 10 0.85 
Slow wave sleep [%] 12 ± 9 14 ± 8 0.20 
Periodic limb movements in sleep [/h] 12 ± 27 17 ± 28 0.04 
    
    
Sleep position characteristics    
Supine sleep position [%] 62.2 ± 32.9 34.2 ± 28.5 <0.001 
Lateral sleep position [%] 33.4 ± 30.5 60.0 ± 27.7 <0.001 
Prone sleep position [%] 3.6 ± 12.5 4.9 ± 12.8 0.05 
Transition index [/h] 4.2 ± 7.1 4.5 ± 7.2 0.04 
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Figure 1 Prevalence of supine sleep position in PD patients and control subjects 
and effects on daytime sleepiness 
A: Frequency and distribution in supine sleep position percentages differed 
significantly between Parkinson’s disease (PD) patients and control subjects 
(Co) (p<0.001). 
B: PD patients (black bars) with excessive daytime sleepiness (EDS) had 
more supine sleep than those without EDS (p=0.001). Control subjects (grey 
bars) did not differ in this respect (p=0.07). Error bars indicate standard 
deviations. 
C: PD patients with longer disease duration spent more time in supine body 
position (r=0.391, p<0.001). 
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